Nanobiotix SA
NASDAQ:NBTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nanobiotix SA
NASDAQ:NBTX
|
FR |
|
B
|
BAE Systems PLC
XETRA:BSP
|
UK |
|
Standard Bank Group Ltd
F:SKC2
|
ZA |
|
D
|
Dentsu Group Inc
OTC:DNTUF
|
JP |
|
Greenidge Generation Holdings Inc
NASDAQ:VIP
|
US |
|
A
|
Agora Inc
XBER:9AG1
|
CN |
|
G
|
Groep Brussel Lambert NV
XBER:EAI
|
BE |
|
L
|
Lockheed Martin Corp
XBER:LOM
|
US |
|
P
|
Prosegur Compania de Seguridad SA
SWB:PRHA
|
ES |
|
S&P Global Inc
NYSE:SPGI
|
US |
|
Block Inc
ASX:XYZ
|
US |
|
G
|
Gas Plus SpA
XBER:T9O
|
IT |
|
E
|
Eli Lilly and Co
SWB:LLY
|
US |
|
E
|
E ON SE
PSE:EOAN
|
DE |
|
N
|
Nexgen Energy Ltd
SWB:6NE
|
CA |
|
C
|
Coca-Cola Europacific Partners PLC
SWB:CK0
|
UK |
|
R
|
Rio Tinto PLC
OTC:RTPPF
|
UK |
Bankruptcy Probability
Nanobiotix SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Nanobiotix SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Nanobiotix SA
PAR:NANO
|
1.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
430.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
219B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Nanobiotix SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Nanobiotix SA has total debt of 91m EUR. This includes both short-term (0 EUR) and long-term (91m EUR) debt.
You can find a full breakdown on its Balance Sheet.
